Concepedia

Lisa Costelloe

LC

10

Publications

1.1K

Citations

10

H-Index

2007

Active since

Affiliations

St. Vincent's University Hospital(Current)

Trinity College Dublin

Beaumont Hospital

University College Dublin

GW Pharmaceuticals (United Kingdom)

Lisa Costelloe is an author at St. Vincent's University Hospital specializing in medicine, multiple sclerosis, and immunotherapy.

Top concepts

Publications per year

2007–2022

10

Publications

10

CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis

Jean M. Fletcher, Róisín Lonergan, Lisa Costelloe et al. · The Journal of Immunology · 2009 · 467 citations · Full text

, , +19

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy

Orla Tuohy, Lisa Costelloe, Grant Hill-Cawthorne et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 238 citations · Full text

The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)

Lisa Costelloe, Killian O’Rourke, Hugh Kearney et al. · Journal of Neurology Neurosurgery & Psychiatry · 2007 · 135 citations · Full text

IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells

Cheryl Sweeney, Róisín Lonergan, Sharee A. Basdeo et al. · Brain Behavior and Immunity · 2011 · 132 citations · Full text

, , +12

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

Lisa Costelloe, Alan J. Thompson, Cathal Walsh et al. · Journal of Neurology Neurosurgery & Psychiatry · 2008 · 48 citations

Rows per page

1–5 of 10